Megan Lerner to Drug Evaluation, Preclinical
This is a "connection" page, showing publications Megan Lerner has written about Drug Evaluation, Preclinical.
Connection Strength
0.064
-
Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder Permeability. Urology. 2018 Jun; 116:230.e1-230.e7.
Score: 0.037
-
Creation and functional screening of a multi-use peptide library. Proc Natl Acad Sci U S A. 1994 Mar 01; 91(5):1614-8.
Score: 0.028